States can use their prescription drug monitoring programs to detect abuse and misuse of controlled substances, according to a report in the CDC's Morbidity and Mortality Weekly Report Surveillance Summary.
States can use their prescription drug monitoring programs (PDMPs) to detect abuse and misuse of controlled substances, according to a report in the CDC’s Morbidity and Mortality Weekly Report Surveillance Summary.
Researchers analyzed data from PDMPs in California, Delaware, Florida, Idaho, Louisiana, Maine, Ohio, and West Virginia. They found that prescribing practices varied widely among the states despite the fact that they are similar in the prevalence of the conditions controlled substances are used to treat.
According to the researchers, the findings show a need for improved prescribing practices, particularly for opioids, which were prescribed twice as often as stimulants or benzodiazepines in all 8 states.
“Every day, 44 people die in American communities from an overdose of prescription opioids and many more become addicted,” CDC Director Tom Frieden, MD, MPH, said in a statement. “States are on the frontline of witnessing these overdose deaths. This research can help inform their prescription overdose prevention efforts and save lives.”
The researchers found that a small minority of prescribers was responsible for most opioid prescriptions. In Delaware, the top 1% of prescribed in terms of their prescriptions wrote 1 in 4 opioid prescriptions compared with 1 in 8 in Maine. In Delaware this represents approximately 19 opioid prescriptions per day. In all states, the top 10% of prescribers wrote half or more of the opioid prescriptions.
According to the data, multiple-provider episode rates were highest in Ohio and lowest in Louisiana. Only 5 of the 8 states collected method of payment information, and the data showed the percentage paid for by cash for controlled substances varied 3-fold while the percentage paid for by Medicaid varied 6-fold.
“A more comprehensive approach is needed to address the prescription opioid overdose epidemic, including guidance to providers on the risks and benefits of these medications,” said Debra Houry, MD, MPH, director of CDC’s National Center for Injury Prevention and Control.
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been falling. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More